Latest News and Press Releases

Q3 2017 GAAP revenues of $24.2 million (excludes $8.3 million for an upfront license agreement with Royal DSM executed in Q3 and fully paid early in Q4 2017) and Non-GAAP Q3 revenues of $32.5 million...

EMERYVILLE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it is rescheduling the release of its financial results for the third quarter ended September...

HAMBURG, Germany and EMERYVILLE, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- H&R USA (H&R), a company of The Hansen & Rosenthal Group, of Hamburg (Germany), and Novvi LLC today announced...

EMERYVILLE, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2017 after market close on Wednesday,...

EMERYVILLE, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Eduardo Alvarez, an experienced executive who has led...

EMERYVILLE, Calif., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a product development and production...

EMERYVILLE, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a product development and production...

EMERYVILLE, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the Rodman & Renshaw...

Q2 2017 revenues of $25.7 million, up 168% over $9.6 million for Q2 2016Q2 2017 product sales of $12.7 million, up 159% over $4.9 million for Q2 2016Completed equity financing and exceeded target with...

EMERYVILLE, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the closing of the second and final tranche of its previously...